Glenmark Pharma has got final approval from the US health regulator for its cream that is used for treatment of fungal skin infections.
According to a company statement, Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Clotrimazole and Betamethasone Dipropionate cream USP, 1% | 0.05%.
It further added that the product is a generic version of Merck, Sharp and Dohme Corporation’s Lotrisone cream in the same strength.
